Colchicine benefits in treatment of type 2 autoimmune pancreatitis: Study Dr. Shravani Dali23 Oct 2021 10:45 AM ISTIn a rare case, two patients with type 2 autoimmune pancreatitis (AIP) experienced clinical improvement and normalization in serological markers...
Colchicine reduces ischemic events in CAD but causes GI upset: Study Dr. Shravani Dali12 Aug 2021 9:00 AM ISTColchicine tends to decrease risk of ischemic events in patients with coronary artery disease but increases the incidences of gastrointestinal...
Colchicine, a potential first-line treatment for cutaneous polyarteritis nodosa: Study Medha Baranwal9 Aug 2021 8:15 PM ISTParis: Colchicine is a reasonable first-line treatment for cutaneous polyarteritis nodosa (cPAN) without peripheral sensory neuropathy and has a...
Drug interaction of DPP4 Inhibitors with some drugs precipitates Hypoglycemia: Study Dr Kartikeya Kohli19 Jun 2021 11:00 AM ISTDipeptidyl peptidase-4 inhibitors (DPP-4i's), also known as gliptins, are among the newest categories of antidiabetic medications (ADMs). The major...
DCGI nod to CSIR-Laxai Colchicine trials in Covid-19 patients Ruchika Sharma12 Jun 2021 11:00 AM ISTNew Delhi: Laxai Life Sciences, Hyderabad, and Council of Scientific & Industrial Research (CSIR), have been given the regulatory approval by...
Colchicine beneficial in COVID-19 RTCPR confirmed cases, Lancet study dr. Abhimanyu Uppal2 Jun 2021 9:00 AM ISTEvidence suggests a role for excessive inflammation in COVID-19 complications. Colchicine, an oral anti-inflammatory medication is hypothesized to...
Colchicine effective option for non-hospitalized COVID-19 patients at risk of complications: Lancet Dr Kartikeya Kohli29 May 2021 8:45 AM ISTResearchers at Montreal Health Innovation Coordinating Centre (MHICC) have found in a phase 3, randomised, double-blinded, adaptive,...
Colchicine significantly lowers CV events in chronic coronary disease: LoDoCo2 trial Medha Baranwal31 Aug 2020 8:27 PM ISTDelhi: Once-daily use of 0.5 mg of colchicine significantly lowers the risk of cardiovascular events in patients with chronic coronary...
Colchicine may reduce COVID-19 complications, hypothesize researchers Dr. Kamal Kant Kohli25 March 2020 8:41 AM ISTCanadian researchers have found that drug colchicine a powerful anti-inflammatory drug may reduce risks of pulmonary complications and death related...
